Affiliation:
1. Capital Medical University
2. Beijing Institute of Hepatology, Capital Medical University
Abstract
Abstract
Background
LCSCs is a key factor in the occurrence and development of HCC. Hydrogen sulphide (H2S) is the third gas signalling molecule after carbon monoxide (CO) and nitrogen monoxide (NO). Exogenous H2S has been shown to inhibit the progression of HCC by increasing apoptosis and autophagy. However, whether H2S can affect LCSCs in HCC microenvironment still remains poorly understand.
Methods
In vitro, Flow cytometry (FCM), imaging quantitive flow cytometry, RNA-sequencing, and Tumor sphere-forming assay were carried out in the HCC cells and LCSCs to investigate the effect of H2S on biological functions and Wnt/β-catenin signaling pathway. Data was analyzed using unpaired Student's t-test and nonlinear regression. P < 0.05 was considered to indicate a statistically significant difference.
Results
Based on the FCM, we found that exogenous H2S were able to induce HCC cells apoptosis and promote stemness in HCC cells. RNA-sequencing, imaging quantitive flow cytometry showed that 23 genes was regulated in NaHS group, and NaHS can activate the Wnt/β-catenin signaling pathway in HCC cell lines. Treatment with the Wnt/β-catenin signaling inhibitor ICRT3 alleviated the NaHS-induced stemness increase in HepG2 and Hep3B cells. Furthermore, the tumor sphere-forming assay show that the number of sphere-forming cells was significantly increased in NaHS treated group and was inhibited significantly in ICRT3 treated group.
Conclusion
Exogenous H2S increased the expression of CD133, CD44 and β-catenin and promoted the stemness in LCSCs by activating the Wnt/β-catenin signalling, which strongly clarify the relationship between Exogenous H2S and LCSC stemness and may provide theoretical guidance and potential therapeutic approaches for liver cancer.
Publisher
Research Square Platform LLC
Reference30 articles.
1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries;Sung H;CA: a cancer journal for clinicians,2021
2. Percutaneous Ablation for Hepatocellular Carcinoma;Weinstein JL;AJR American journal of roentgenology,2018
3. Hepatocellular Carcinoma: The Role of Interventional Oncology;Donadon M;Liver cancer,2016
4. Hepatocellular carcinoma. Nature reviews Disease primers 2021, 7(1):7.
5. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray F;CA: a cancer journal for clinicians,2018